ORILUKAST 4 mg Tablets

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(36)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use Orilukast

Contents of the leaflet

  1. Package Leaflet: Information for the User
  2. Orilukast, 4 mg, Chewable Tablets
    1. Read the package leaflet carefully before giving this medicine to a child, as it contains important information for the patient.
    2. Table of Contents of the Package Leaflet:
  3. What is Orilukast and what is it used for
    1. What is Orilukast
    2. How Orilukast works
    3. When to use Orilukast
    4. What is asthma?
  4. Important information before giving Orilukast to a child
    1. When not to give Orilukast to a child
    2. Warnings and precautions
    3. Various neuropsychiatric events (such as changes in behavior and mood, depression, and suicidal tendencies) have been reported in patients of all ages treated with montelukast (see section 4). If the patient experiences such symptoms while taking montelukast, consult a doctor.
    4. Children and adolescents
    5. Orilukast and other medicines
    6. Orilukast with food and drink
    7. Pregnancy and breastfeeding
    8. Driving and using machines
    9. Orilukast contains aspartame
  5. How to give Orilukast
    1. For children from 2 to 5 years old
    2. Using more Orilukast than recommended in a child
    3. Missing a dose of Orilukast
    4. Stopping Orilukast treatment
  6. Possible side effects
    1. Severe side effects
    2. Other side effects reported after the medicine was marketed
    3. Reporting side effects
  7. How to store Orilukast
  8. Contents of the pack and other information
    1. What Orilukast contains
    2. What Orilukast looks like and contents of the pack
    3. Marketing authorization holder
    4. Manufacturer
    5. This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Package Leaflet: Information for the User

Orilukast, 4 mg, Chewable Tablets

For children from 2 to 5 years old
montelukast

Read the package leaflet carefully before giving this medicine to a child, as it contains important information for the patient.

  • Keep this package leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for a specific child. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
  • If the child experiences any side effects, including any not listed in this leaflet, tell the doctor or pharmacist. See section 4.

Table of Contents of the Package Leaflet:

  • 1. What is Orilukast and what is it used for
  • 2. Important information before giving Orilukast to a child
  • 3. How to give Orilukast
  • 4. Possible side effects
  • 5. How to store Orilukast
  • 6. Contents of the pack and other information
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What is Orilukast and what is it used for

What is Orilukast

Orilukast is a leukotriene receptor antagonist that blocks substances called leukotrienes.

How Orilukast works

Leukotrienes cause narrowing and swelling of the airways in the lungs. By blocking leukotrienes, Orilukast relieves asthma symptoms and helps control the condition.

When to use Orilukast

The doctor has prescribed Orilukast to treat asthma in the child, to prevent asthma symptoms from occurring during the day and at night.

  • Orilukast is used to treat patients aged 2 to 5 years who have not achieved adequate asthma control with their current medications and require additional treatment.
  • Orilukast may also be used as an alternative to inhaled corticosteroids in patients aged 2 to 5 years who have not recently used inhaled corticosteroids to treat asthma and in patients who are unable to use inhaled corticosteroids.
  • Orilukast also helps prevent exercise-induced narrowing of the airways in patients aged 2 years and older.

The doctor will determine how to give Orilukast based on the child's symptoms and the severity of their asthma.

What is asthma?

Asthma is a chronic disease.
In asthma, there are:

  • breathing difficulties due to narrowing of the airways. This narrowing of the airways worsens and improves in response to various conditions.
  • airway hypersensitivity, which reacts to many factors, such as cigarette smoke, plant pollen, cold air, or physical exertion.
  • swelling (inflammation) of the lining of the airways.

Asthma symptoms include: coughing, wheezing, and a feeling of tightness in the chest.

2. Important information before giving Orilukast to a child

Tell the doctor if the child has or has had any diseases or allergies.

When not to give Orilukast to a child

  • if the child is allergic to montelukast or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Before giving Orilukast to a child, discuss this with the doctor or pharmacist.

  • If the child's asthma symptoms worsen or have difficulty breathing, tell the doctor immediately.
  • Orilukast is not intended for the treatment of acute asthma attacks. If an attack occurs, follow the doctor's instructions. Always have a rescue medication available for the child in case of an asthma attack.
  • It is essential that the child takes all asthma medications prescribed by the doctor. Do not give Orilukast instead of other asthma medications prescribed by the doctor for the child.
  • Remember to consult the doctor if the child taking asthma medications experiences symptoms such as flu-like symptoms, tingling or numbness in the hands or feet, worsening respiratory symptoms, and/or rash.
  • Do not give the child aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) if they worsen the child's asthma.

Various neuropsychiatric events (such as changes in behavior and mood, depression, and suicidal tendencies) have been reported in patients of all ages treated with montelukast (see section 4). If the patient experiences such symptoms while taking montelukast, consult a doctor.

Consult a doctor if the patient experiences such symptoms while taking montelukast.

Children and adolescents

Do not give this medicine to children under 2 years of age.
For children and adolescents under 18 years of age, other forms of this medicine are available, suitable for the patient's age.

Orilukast and other medicines

Tell the doctor or pharmacist about all medicines the child is taking or has recently taken, including those obtained without a prescription.
Some medicines may affect how Orilukast works or Orilukast may affect how other medicines work.
Before giving Orilukast, tell the doctor if the child is taking:

  • phenobarbital (used to treat epilepsy);
  • phenytoin (used to treat epilepsy);
  • rifampicin (used to treat tuberculosis and some other infections).

Orilukast with food and drink

Do not give Orilukast 4 mg chewable tablets with food;
give the tablets at least 1 hour before a meal or 2 hours after a meal.

Pregnancy and breastfeeding

This section does not apply to Orilukast 4 mg chewable tablets, as they are intended for use in children aged 2 to 5 years.

Driving and using machines

This section does not apply to Orilukast 4 mg chewable tablets, as they are intended for use in children aged 2 to 5 years; however, the following information applies to the active substance, montelukast.
It is unlikely that Orilukast will affect the ability to drive or use machines. However, the reaction to the medicine may vary among individual patients.
Some side effects (such as dizziness and drowsiness) that occurred during Orilukast treatment may affect the ability to drive or use machines in some patients.

Orilukast contains aspartame

The medicine contains 0.3 mg of aspartame in each tablet. Aspartame is a source of phenylalanine. It may be harmful to patients with phenylketonuria. This is a rare genetic disorder in which phenylalanine accumulates in the body due to its improper elimination.
Other excipients
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to give Orilukast

Always give this medicine to a child as directed by the doctor or pharmacist. If you are unsure, ask the doctor or pharmacist.

  • Give this medicine to the child under adult supervision.
  • Give the child only one Orilukast chewable tablet once daily as directed by the doctor.
  • Give the medicine even if the child has no symptoms or if an acute asthma attack occurs.

For children from 2 to 5 years old

The recommended dose is one 4 mg chewable tablet per day, in the evening.
If the child is taking Orilukast, ensure they do not take any other medicines containing the same active substance, montelukast.
This medicine is for oral use only.
The tablet can be chewed or swallowed. If the tablet is to be swallowed, it should be taken with a sufficient amount of liquid (e.g., a glass of water).
Do not give Orilukast 4 mg chewable tablets with food; give the medicine at least 1 hour before a meal or 2 hours after a meal.

Immediately contact the child's doctor for advice.
In most reports of overdose, no side effects were reported. The most commonly reported symptoms of overdose in adults and children were: stomach pain, drowsiness, excessive thirst, headache, vomiting, and hyperactivity.

Missing a dose of Orilukast

Try to give Orilukast as directed by the doctor. However, if the child misses a dose, simply return to the usual dosing schedule - one chewable tablet once daily.
Do not give a double dose to make up for a missed dose.

Stopping Orilukast treatment

Orilukast will only treat the child's asthma if it is taken regularly.
It is essential that the child takes Orilukast regularly for as long as the doctor recommends. This will help keep the child's asthma under control.
If you have any further questions about this medicine, ask the doctor or pharmacist.

4. Possible side effects

Like all medicines, Orilukast can cause side effects, although not everybody gets them.
During clinical trials with montelukast 4 mg chewable tablets, the most commonly reported side effects (may affect up to 1 in 10 people)considered related to montelukast were:

  • stomach pain
  • excessive thirst.

In addition, in clinical trials with montelukast 10 mg film-coated tablets and 5 mg chewable tablets, the following were reported:

  • headache.

These symptoms were usually mild and occurred more frequently in patients taking montelukast than in patients taking a placebo (a tablet that does not contain any medicine).

Severe side effects

Immediately contact the doctorif the child experiences any of the following severe side effects, which may require immediate medical attention.
Uncommon (may affect up to 1 in 100 people)

  • allergic reactions, including swelling of the face, lips, tongue, and/or throat, which may cause difficulty breathing or swallowing
  • changes in behavior and mood: agitation, including aggressive behavior or hostility, depression
  • seizures.

Rare (may affect up to 1 in 1,000 people)

  • increased tendency to bleed
  • tremors
  • heart palpitations.

Very rare (may affect up to 1 in 10,000 people)

  • a syndrome of symptoms such as flu-like symptoms, tingling or numbness in the hands and feet, worsening respiratory symptoms, and/or rash (Churg-Strauss syndrome) (see section 2)
  • low platelet count
  • changes in behavior and mood: hallucinations, disorientation, suicidal thoughts and attempts
  • inflammation (inflammation) of the lungs
  • severe skin reactions (erythema multiforme), which may occur without prior warning, inflammation of the liver.

Other side effects reported after the medicine was marketed

Very common (may affect more than 1 in 10 people):

  • upper respiratory tract infection.

Common (may affect up to 1 in 10 people):

  • diarrhea, nausea, vomiting
  • rash
  • fever
  • increased liver enzyme activity.

Uncommon (may affect up to 1 in 100 people):

  • changes in behavior and mood: sleep disturbances, including nightmares, difficulty falling asleep, sleepwalking, irritability, restlessness, hyperactivity
  • dizziness, drowsiness, tingling, and/or numbness
  • nosebleeds
  • dry mouth, indigestion
  • bruising, itching, hives
  • joint or muscle pain, muscle cramps
  • bedwetting in children
  • weakness/fatigue, malaise, swelling.

Rare (may affect up to 1 in 1,000 people):

  • changes in behavior and mood: attention disturbances, memory disturbances, uncontrolled muscle movements.

Very rare (may affect up to 1 in 10,000 people):

  • tender red lumps under the skin, most often on the shins (erythema nodosum), severe skin reactions (erythema multiforme), which may occur without warning
  • changes in behavior and mood: obsessive-compulsive symptoms, stuttering.

Reporting side effects

If the child experiences any side effects, including any not listed in this leaflet, tell the doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: + 48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Orilukast

Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister. The expiry date refers to the last day of the month.
There are no special storage instructions for the medicinal product.
Store in the original package to protect from light and moisture.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

What Orilukast contains

  • The active substance is montelukast. Each chewable tablet contains 4 mg of montelukast as 4.16 mg of montelukast sodium.
  • The other ingredients are: microcrystalline cellulose, sodium croscarmellose, magnesium stearate, aspartame (E951), iron oxide red (E172), mannitol (E421), cherry flavor.

What Orilukast looks like and contents of the pack

Orilukast 4 mg chewable tablets are pink, oval, biconvex, uncoated tablets with a score line on both sides. The tablet can be divided into equal doses.
The tablets are packaged in aluminum/aluminum blisters. The blisters are packaged in cardboard boxes.
Package sizes: 28, 56, 98 tablets.
Not all package sizes may be marketed.

Marketing authorization holder

Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland

Manufacturer

Orion Corporation Orion Pharma
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation, Orion Pharma
Joensuunkatu 7
FI-24100 Salo
Finland
To obtain more detailed information on this medicine, contact the local representative of the marketing authorization holder:
Orion Pharma Poland Sp. z o. o.
[email protected]

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Poland: Orilukast
Date of last revision of the leaflet: 26.02.2024

Online doctors for Orilukast

Discuss questions about Orilukast, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

Doctor
5.0(36)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Book a video appointment
€86
Doctor
5.0(12)

Yevgen Yakovenko

Family medicine12 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Book a video appointment
€72
Doctor
5.0(3)

Lina Travkina

Family medicine13 years of experience

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Book a video appointment
€75
Doctor
5.0(2)

Dmytro Horobets

Family medicineEndocrinology7 years of experience

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Book a video appointment
€71
Doctor
5.0(19)

Nuno Tavares Lopes

Family medicineGeneral medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70

Get Orilukast Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for Orilukast?

Orilukast requires a prescription in Poland. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in Orilukast?

The active ingredient in Orilukast is montelukast. This information helps identify medicines with the same composition but different brand names.

Who manufactures Orilukast?

Orilukast is manufactured by Orion Corporation Orion Corporation, Orion Pharma. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of Orilukast online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Orilukast is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy Orilukast in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy Orilukast in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to Orilukast?

Other medicines with the same active substance (montelukast) include Asmenol Pph, Asmenol Pph, Asmenol. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media